Offir Ukashi

17PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 05, 2026
Multimodal monitoring of pan-enteric mucosal healing and biologic persistence in Crohn's disease-the MILESTONE-CD prospective cohort.

|Jun 15, 2026
Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.

|Sep 07, 2025
Vedolizumab Achieves Pan-Enteric Mucosal Healing in Crohn's Disease: A Prospective Observational Study.

Offir Ukashi, Adi Lahat, Bella Ungar

|Jun 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.

Uria Shani, Monica State, Radu Bogdan Mateescu

|Jan 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.

Offir Ukashi, Aurelien Amiot, David Laharie

|Jan 08, 2025
Genetic Risk of Ankylosing Spondylitis and Second-Line Therapy Need in Crohn's Disease: A Mendelian Randomization Study.

Mahmud Omar, Mohammad Omar, Yonatan Shneor Patt

Pageof 3

Frequent Collaborators

13 joint publications

Uri Kopylov

6 joint publications

Adi Lahat

4 joint publications

Ahmad Albshesh

3 joint publications

Shelly Soffer